$TDOC
Teladoc Health, Inc. Stock $tdoc

$tdoc Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000155837023002559 Filed on March 01, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$629.2M	$637.7M	$2.407B
YoY Change	11.3%	15.06%	18.41%
Cost Of Revenue	$190.1M	$188.9M	$744.0M
YoY Change	1.65%	7.94%	14.41%
Gross Profit	$439.1M	$448.8M	$1.663B
YoY Change	16.07%	18.35%	20.28%
Gross Profit Margin	69.79%	70.38%	69.09%
Selling, General & Admin	$345.4M	$324.2M	$677.0M
YoY Change	111.59%	11.45%	-1.68%
% of Gross Profit	78.66%	72.24%	40.71%
Research & Development	$86.99M	$77.58M	$333.6M
YoY Change	-0.49%	6.46%	6.97%
% of Gross Profit	19.81%	17.28%	20.06%
Depreciation & Amortization	$70.46M	$76.39M	$256.0M
YoY Change	19.57%	45.97%	25.36%
% of Gross Profit	16.05%	17.02%	15.4%
Operating Expenses	$502.2M	$477.5M	$1.011B
YoY Change	100.35%	14.76%	1.02%
Operating Profit	-$63.06M	-$28.70M	-$13.65B
YoY Change	-99.05%	-22.16%	5039.92%
Interest Expense	$3.648M	$1.893M	-$9.270M
YoY Change	-166.57%	-110.03%	-88.47%
% of Operating Profit
Other Income/Expense, Net	$4.907M	$1.748M	-$859.0K
YoY Change	577.76%	-531.6%	-116.88%
Pretax Income	-$68.55M	-$3.812B	-$13.66B
YoY Change	-98.97%	6177.23%	3452.09%
Income Tax	$681.0K	-$1.841M	-$3.812M
% Of Pretax Income
Net Earnings	-$69.23M	-$3.810B	-$13.66B
YoY Change	-98.96%	34584.31%	3085.58%
Net Earnings / Revenue	-11.0%	-597.46%	-567.53%
Basic Earnings Per Share	-$0.42		-$84.60
Diluted Earnings Per Share	-$0.42	-$23.49	-$84.60
COMMON SHARES
Basic Shares Outstanding	162.6M	161.9M	161.5M
Diluted Shares Outstanding	162.9M		161.5M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$888.6M	$918.2M	$918.2M
YoY Change	5.91%	2.48%	2.47%
Cash & Equivalents	$888.6M	$918.2M	$918.2M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$136.3M	$12.10M	$105.2M
YoY Change	2460.01%	113.85%	20.41%
Inventory	$45.80M	$56.34M	$56.34M
Prepaid Expenses	$77.53M	$63.16M
Receivables	$216.0M	$210.6M	$210.6M
Other Receivables	$0.00	$25.09M	$25.09M
Total Short-Term Assets	$1.287B	$1.315B	$1.315B
YoY Change	6.51%	7.34%	7.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$69.31M	$29.64M	$71.47M
YoY Change	143.88%	8.84%	-3.43%
Goodwill	$1.073B	$1.073B
YoY Change	-86.41%	-92.6%
Intangibles	$1.816B	$1.837B
YoY Change	-3.61%	-3.85%
Long-Term Investments
YoY Change
Other Assets	$63.99M	$48.54M	$48.54M
YoY Change	140.31%	134.46%	134.46%
Total Long-Term Assets	$3.022B	$3.030B	$3.030B
YoY Change	-69.42%	-81.65%	-81.65%
TOTAL ASSETS
Total Short-Term Assets	$1.287B	$1.315B	$1.315B
Total Long-Term Assets	$3.022B	$3.030B	$3.030B
Total Assets	$4.309B	$4.345B	$4.345B
YoY Change	-61.15%	-75.5%	-75.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$38.63M	$47.69M	$47.69M
YoY Change	-18.53%	0.92%	0.92%
Accrued Expenses	$235.5M	$193.4M	$193.4M
YoY Change	84.44%	19.4%	19.4%
Deferred Revenue		$101.8M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.25M	$11.38M	$11.38M
YoY Change	-11.19%		-14.56%
Total Short-Term Liabilities	$381.3M	$399.8M	$399.8M
YoY Change	24.34%	20.77%	20.77%
LONG-TERM LIABILITIES
Long-Term Debt	$1.544B	$1.543B	$1.543B
YoY Change	0.2%	24.97%	24.97%
Other Long-Term Liabilities	$41.79M	$1.618M	$43.53M
YoY Change	2792.25%	8.45%	-7.57%
Total Long-Term Liabilities	$1.586B	$1.618M	$1.587B
YoY Change	109655.29%	8.45%	23.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$381.3M	$399.8M	$399.8M
Total Long-Term Liabilities	$1.586B	$1.618M	$1.587B
Total Liabilities	$2.018B	$401.4M	$2.038B
YoY Change	554.89%	20.72%	20.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.08B	-$15.01B
YoY Change	87.92%	955.84%
Common Stock	$17.41B	$17.36B
YoY Change	1.35%	-0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.291B	$2.308B	$2.308B
YoY Change
Total Liabilities & Shareholders Equity	$4.309B	$4.345B	$4.345B
YoY Change	-61.15%	-75.5%	-75.5%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$69.23M	-$3.810B	-$13.66B
YoY Change	-98.96%	34584.31%	3085.58%
Depreciation, Depletion And Amortization	$70.46M	$76.39M	$256.0M
YoY Change	19.57%	45.97%	25.36%
Cash From Operating Activities	$13.16M	$65.55M	$189.3M
YoY Change	-141.44%	-21.22%	-2.42%
INVESTING ACTIVITIES
Capital Expenditures	$45.62M	$53.89M	$16.48M
YoY Change	1065.96%	-335.12%	93.11%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$0.00	$0.00	-$2.514M
YoY Change	-100.0%	-100.0%	-71.15%
Cash From Investing Activities	-$45.62M	-$53.89M	-$167.7M
YoY Change	65.5%	168.45%	129.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.353M	4.381M	6.497M
YoY Change	19.07%	-33.87%	-84.13%
NET CHANGE
Cash From Operating Activities	13.16M	65.55M	189.3M
Cash From Investing Activities	-45.62M	-53.89M	-167.7M
Cash From Financing Activities	3.353M	4.381M	6.497M
Net Change In Cash	-29.12M	16.04M	28.05M
YoY Change	-48.47%	-77.01%	-82.68%
FREE CASH FLOW
Cash From Operating Activities	$13.16M	$65.55M	$189.3M
Capital Expenditures	$45.62M	$53.89M	$16.48M
Free Cash Flow	-$32.47M	$11.66M	$172.8M
YoY Change	-8.95%	-89.02%	-6.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3872000
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3834000
CY2022Q4	tdoc	Advances From Financing Companies Noncurrent AdvancesFromFinancingCompaniesNoncurrent	8082000
CY2021Q4	tdoc	Advances From Financing Companies Noncurrent AdvancesFromFinancingCompaniesNoncurrent	9291000
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	5204000
CY2022Q2	tdoc	Goodwill Impairment Loss Per Share GoodwillImpairmentLossPerShare	18.77
CY2022Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3748000
CY2020	tdoc	Effective Income Tax Rate Reconciliation Acquisition Expenses EffectiveIncomeTaxRateReconciliationAcquisitionExpenses	-0.022
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.067
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.469
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.054
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.010
CY2022	tdoc	Effective Income Tax Rate Reconciliation Acquisition Expenses EffectiveIncomeTaxRateReconciliationAcquisitionExpenses	0.000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.115
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.158
CY2021	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	267837000
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.teladoc.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001477449
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162840360
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	160469325
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022	us-gaap	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#DepreciationAndAmortization
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.teladoc.com/20221231#AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent
CY2020Q4	tdoc	Exercise Price Adjustment Ratio Closing Price Threshold Trading Days ExercisePriceAdjustmentRatioClosingPriceThresholdTradingDays	P4D
CY2020Q4	tdoc	Exercise Price Adjustment Ratio Closing Price Threshold Trading Days ExercisePriceAdjustmentRatioClosingPriceThresholdTradingDays	P4D
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37477
CY2022	dei	Entity Registrant Name EntityRegistrantName	TELADOC HEALTH, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3705970
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Manhattanville Road
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 203
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Purchase
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10577
CY2022	dei	City Area Code CityAreaCode	203
CY2022	dei	Local Phone Number LocalPhoneNumber	635-2002
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	TDOC
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022Q2	dei	Entity Public Float EntityPublicFloat	5334035010
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	162617192
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	918182000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	893480000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2537000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14800000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12384000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	210554000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	168956000
CY2022Q4	us-gaap	Inventory Net InventoryNet	56342000
CY2021Q4	us-gaap	Inventory Net InventoryNet	73079000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	130310000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87387000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1315388000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1225439000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29641000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27234000
CY2022Q4	us-gaap	Goodwill Goodwill	1073190000
CY2021Q4	us-gaap	Goodwill Goodwill	14504174000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1836765000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1910278000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41831000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	46780000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48540000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	20703000
CY2022Q4	us-gaap	Assets Assets	4345355000
CY2021Q4	us-gaap	Assets Assets	17734608000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47690000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	47257000
CY2022Q4	tdoc	Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent	168693000
CY2021Q4	tdoc	Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent	102933000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	81554000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	91941000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	90457000
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	75569000
CY2022Q4	tdoc	Advances From Financing Companies Current AdvancesFromFinancingCompaniesCurrent	11375000
CY2021Q4	tdoc	Advances From Financing Companies Current AdvancesFromFinancingCompaniesCurrent	13313000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	399769000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	331013000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1618000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1492000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38042000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	41773000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	50939000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	75777000
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1535288000
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	1225671000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162840360
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	160469325
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	163000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	160000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	17358645000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	17473336000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15008287000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1421454000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-42776000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6285000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2307745000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16045757000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4345355000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17734608000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2406840000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2032707000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1093962000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	743987000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	650258000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	390829000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	623536000
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	416726000
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	226146000
CY2022	us-gaap	Selling Expense SellingExpense	227172000
CY2021	us-gaap	Selling Expense SellingExpense	250581000
CY2020	us-gaap	Selling Expense SellingExpense	154052000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	333629000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	311884000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	164941000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	449855000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	438007000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	506684000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	15620000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	26643000
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	88236000
CY2022	us-gaap	Restructuring Costs RestructuringCosts	7416000
CY2021	us-gaap	Restructuring Costs RestructuringCosts	0
CY2020	us-gaap	Restructuring Costs RestructuringCosts	0
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	256027000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	204239000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	69495000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13402812000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	16060054000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2298338000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	1600383000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-13653214000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-265631000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-506421000
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-43748000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9077000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-859000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5088000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-545000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9270000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-80365000
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-59950000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13663343000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-384656000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-575993000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3812000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44137000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-90857000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13659531000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-428793000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-485136000
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-36491000
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-24803000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	35757000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13696022000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-453596000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-449379000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-84.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-84.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.73
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.73
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.36
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	161457123
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161457123
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156939349
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156939349
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90509229
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90509229
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1014025000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54314000
CY2020	tdoc	Stock Issued During Period Value Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits	-23705000
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4722000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	13884921000
CY2020	tdoc	Adjustments To Additional Paid In Capital Sale Of Capped Call Related To Livongo Notes AdjustmentsToAdditionalPaidInCapitalSaleOfCappedCallRelatedToLivongoNotes	91659000
CY2020	tdoc	Adjustments To Additional Paid In Capital Livongo Notes Guaranteed By Company AdjustmentsToAdditionalPaidInCapitalLivongoNotesGuaranteedByCompany	555448000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	478204000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	35757000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-485136000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	15883804000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	25781000
CY2021	tdoc	Stock Issued During Period Value Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits	0
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	15331000
CY2021	tdoc	Recovered Excess Common Stock Issued For Acquisition Equity Impact RecoveredExcessCommonStockIssuedForAcquisitionEquityImpact	40329000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	315761000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24803000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-428793000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16045757000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5884000
CY2022	tdoc	Stock Issued During Period Value Vesting Of Restricted Stock Units StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits	0
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7064000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	236090000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-36491000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13659531000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2307745000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13659531000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-428793000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-485136000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13402812000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	256027000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	204239000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69495000
CY2022	tdoc	Depreciation Of Rental Equipment DepreciationOfRentalEquipment	2859000
CY2021	tdoc	Depreciation Of Rental Equipment DepreciationOfRentalEquipment	3333000
CY2020	tdoc	Depreciation Of Rental Equipment DepreciationOfRentalEquipment	1697000
CY2022	tdoc	Amortization Of Right Of Use Assets And Depreciation Of Rental Equipment AmortizationOfRightOfUseAssetsAndDepreciationOfRentalEquipment	11757000
CY2021	tdoc	Amortization Of Right Of Use Assets And Depreciation Of Rental Equipment AmortizationOfRightOfUseAssetsAndDepreciationOfRentalEquipment	12049000
CY2020	tdoc	Amortization Of Right Of Use Assets And Depreciation Of Rental Equipment AmortizationOfRightOfUseAssetsAndDepreciationOfRentalEquipment	6895000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	15398000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	16941000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5284000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	217852000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	302586000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	475531000
CY2022	tdoc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-7840000
CY2021	tdoc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	41800000
CY2020	tdoc	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-90158000
CY2022	tdoc	Accretion Of Interest AccretionOfInterest	3345000
CY2021	tdoc	Accretion Of Interest AccretionOfInterest	61253000
CY2020	tdoc	Accretion Of Interest AccretionOfInterest	45296000
CY2022	tdoc	Gain Loss On Extinguishment Of Debt Cash Flow Impact GainLossOnExtinguishmentOfDebtCashFlowImpact	0
CY2021	tdoc	Gain Loss On Extinguishment Of Debt Cash Flow Impact GainLossOnExtinguishmentOfDebtCashFlowImpact	-40652000
CY2020	tdoc	Gain Loss On Extinguishment Of Debt Cash Flow Impact GainLossOnExtinguishmentOfDebtCashFlowImpact	-9077000
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	5901000
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-7584000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3845000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1009000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	61641000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17510000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21091000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	41081000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	31090000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12565000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-14800000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19494000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	24732000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27767000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3547000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8135000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1876000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1188000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-87995000
CY2022	tdoc	Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation	61217000
CY2021	tdoc	Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation	18175000
CY2020	tdoc	Increase Decrease In Accrued Liabilities And Other Current Liabilities Excluding Accrued Compensation IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilitiesExcludingAccruedCompensation	20125000
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-12290000
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4675000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	34819000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	15240000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20554000
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	17751000
CY2022	tdoc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-11525000
CY2021	tdoc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-16532000
CY2020	tdoc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-6300000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	200000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2607000
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2360000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	189292000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	193990000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53511000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16480000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8534000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4024000
CY2022	us-gaap	Payments For Software PaymentsForSoftware	156284000
CY2021	us-gaap	Payments For Software PaymentsForSoftware	55400000
CY2020	us-gaap	Payments For Software PaymentsForSoftware	22018000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2507000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	50000000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2496000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	10901000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	78663000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	567429000
CY2022	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2514000
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-8715000
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167743000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72981000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-590975000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5884000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	25781000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54314000
CY2022	tdoc	Proceeds From Sale Of Capped Call Related To Livongo Notes ProceedsFromSaleOfCappedCallRelatedToLivongoNotes	0
CY2021	tdoc	Proceeds From Sale Of Capped Call Related To Livongo Notes ProceedsFromSaleOfCappedCallRelatedToLivongoNotes	0
CY2020	tdoc	Proceeds From Sale Of Capped Call Related To Livongo Notes ProceedsFromSaleOfCappedCallRelatedToLivongoNotes	91659000
CY2022	tdoc	Proceeds From Advances From Financing Companies ProceedsFromAdvancesFromFinancingCompanies	11873000
CY2021	tdoc	Proceeds From Advances From Financing Companies ProceedsFromAdvancesFromFinancingCompanies	15275000
CY2020	tdoc	Proceeds From Advances From Financing Companies ProceedsFromAdvancesFromFinancingCompanies	6002000
CY2022	tdoc	Payments From Customers Against Advances From Financing Companies PaymentsFromCustomersAgainstAdvancesFromFinancingCompanies	15020000
CY2021	tdoc	Payments From Customers Against Advances From Financing Companies PaymentsFromCustomersAgainstAdvancesFromFinancingCompanies	16050000
CY2020	tdoc	Payments From Customers Against Advances From Financing Companies PaymentsFromCustomersAgainstAdvancesFromFinancingCompanies	8635000
CY2022	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	0
CY2021	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	0
CY2020	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	10000000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	6501000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	16810000
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4722000
CY2022	tdoc	Cash Related To Tax Withholding For Share Based Compensation Net CashRelatedToTaxWithholdingForShareBasedCompensationNet	124000
CY2021	tdoc	Cash Related To Tax Withholding For Share Based Compensation Net CashRelatedToTaxWithholdingForShareBasedCompensationNet	3422000
CY2020	tdoc	Cash Related To Tax Withholding For Share Based Compensation Net CashRelatedToTaxWithholdingForShareBasedCompensationNet	-26703000
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2865000
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4152000
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6497000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40947000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	859136000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	28046000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	161956000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	214650000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3344000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1800000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4321000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	893480000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	733324000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	514353000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	918182000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	893480000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	733324000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2512000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3974000
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1324000
CY2022	us-gaap	Interest Paid InterestPaid	17361000
CY2021	us-gaap	Interest Paid InterestPaid	18837000
CY2020	us-gaap	Interest Paid InterestPaid	14890000
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Note 1. Organization and Description of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">Teladoc, Inc. was incorporated in the State of Texas in June 2002 and changed its state of incorporation to the State of Delaware in October 2008. Effective August 10, 2018, Teladoc, Inc. changed its corporate name to Teladoc Health, Inc. Unless the context otherwise requires, Teladoc Health, Inc., together with its subsidiaries, is referred to herein as “Teladoc Health” or the “Company”. The Company’s principal executive office is located in Purchase, New York. Teladoc Health is the global leader in whole person virtual care focused on forging a new healthcare experience with better convenience, outcomes and value around the world.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">On October 30, 2020, the Company completed the merger with Livongo Health, Inc. (“Livongo”), a transformational opportunity to improve the delivery, access and experience of chronic healthcare for individuals around the world. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">On July 1, 2020, the Company completed the acquisition of InTouch Technologies, Inc. (“InTouch”), a leading provider of enterprise telehealth solutions for hospitals and health systems.</p>
CY2022	tdoc	Number Of Professional Associations Consolidated As Variable Interest Entities NumberOfProfessionalAssociationsConsolidatedAsVariableInterestEntities	3
CY2022	tdoc	Number Of Professional Corporations Consolidated As Variable Interest Entities NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities	12
CY2022	tdoc	Number Of Professional Corporations Consolidated As Variable Interest Entities NumberOfProfessionalCorporationsConsolidatedAsVariableInterestEntities	12
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates on historical experience, current business and economic factors, and various other assumptions that the Company believes are necessary to form a basis for making judgments about the carrying values of assets and liabilities, the recorded amounts of revenue and expenses, and the disclosure of contingent assets and liabilities. The Company is subject to uncertainties such as the impact of future events, economic and political factors, and changes in the Company’s business environment; therefore, actual results could differ from these estimates. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment evolves. The Company believes that estimates used in the preparation of these consolidated financial statements are reasonable; however, actual results could differ materially from these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">Changes in estimates are made when circumstances warrant. Such changes in estimates and refinements in estimation methodologies are reflected in the Consolidated Statement of Operations; if material, the effects of changes in estimates are disclosed in the Notes to Consolidated Financial Statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">Significant estimates and assumptions by management affect areas including the value and useful life of long-lived assets (including intangible assets), the value of goodwill, the capitalization and amortization of software development costs, deferred device and contract costs, allowances for sales and for doubtful accounts, and the accounting for business combinations. Other significant areas include revenue recognition (including performance guarantees), the accounting for income taxes, contingencies, litigation and related legal accruals, and the accounting for stock-based compensation awards.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:9pt;visibility:hidden;"></span></p>
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	tdoc	Contract With Customer Term ContractWithCustomerTerm	P1Y
CY2022	tdoc	Payment Terms PaymentTerms	P30D
CY2022	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	4400000
CY2021	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	5600000
CY2020	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	1900000
CY2022	tdoc	Contract With Customer Refunds Issued ContractWithCustomerRefundsIssued	79200000
CY2021	tdoc	Contract With Customer Refunds Issued ContractWithCustomerRefundsIssued	67000000.0
CY2020	tdoc	Contract With Customer Refunds Issued ContractWithCustomerRefundsIssued	33500000
CY2022	tdoc	Amortization Term Of Deferred Contract Cost AmortizationTermOfDeferredContractCost	P4Y
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	106900000
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	99500000
CY2020	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	110800000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	918200000
CY2022	us-gaap	Number Of Reporting Units NumberOfReportingUnits	2
CY2022	tdoc	Increase In Amortization Expense Due To Decrease In Useful Life IncreaseInAmortizationExpenseDueToDecreaseInUsefulLife	23200000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	503900000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	297000000.0
CY2020	us-gaap	Advertising Expense AdvertisingExpense	165000000.0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Concentrations of Risk </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable. Although the Company deposits its cash with multiple financial institutions in the U.S. and in foreign countries, its deposits, at times, may exceed federally insured limits. The Company’s short-term investments are comprised of a portfolio of diverse high credit rating instruments with maturity durations of one year or less.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">No Client represented over 10% of revenues for the years ended December 31, 2022, 2021, or 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:10pt 0pt 0pt 0pt;">No Client represented over 10% of accounts receivable at December 31, 2022 or 2021.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">Revenue from Clients located in the U.S. for the years ended December 31, 2022, 2021, and 2020 was $2,101.0 million, $1,774.0 million and $913.7 million, respectively. Revenue from Clients located outside the U.S. for the years ended December 31, 2022, 2021 and 2020 was $305.8 million, $258.7 million, and $180.2 million, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:7pt;visibility:hidden;"></span></p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-indent:36pt;margin:0pt;">Certain prior year amounts have been reclassified to conform to the current year presentation.</p>
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2406840000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2032707000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1093962000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2406840000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2032707000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1093962000
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	94300000
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	79400000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	14900000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	24600000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	73700000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	51000000.0
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	90100000
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4200000
CY2022Q4	tdoc	Deferred Device Cost And Other Current DeferredDeviceCostAndOtherCurrent	29956000
CY2021Q4	tdoc	Deferred Device Cost And Other Current DeferredDeviceCostAndOtherCurrent	22304000
CY2022Q4	tdoc	Deferred Device Cost And Other Noncurrent DeferredDeviceCostAndOtherNoncurrent	8404000
CY2021Q4	tdoc	Deferred Device Cost And Other Noncurrent DeferredDeviceCostAndOtherNoncurrent	6249000
CY2022Q4	tdoc	Deferred Device Cost And Other DeferredDeviceCostAndOther	38360000
CY2021Q4	tdoc	Deferred Device Cost And Other DeferredDeviceCostAndOther	28553000
CY2021Q4	tdoc	Deferred Device Cost And Other DeferredDeviceCostAndOther	28553000
CY2022	tdoc	Deferred Device Cost And Other Additions DeferredDeviceCostAndOtherAdditions	51201000
CY2022	tdoc	Deferred Device Cost And Other Cost Of Revenue Recognized DeferredDeviceCostAndOtherCostOfRevenueRecognized	-41394000
CY2022Q4	tdoc	Deferred Device Cost And Other DeferredDeviceCostAndOther	38360000
CY2021	tdoc	Fair Value Assets And Liabilities Transfers Between Fair Value Measurement Levels Amount FairValueAssetsAndLiabilitiesTransfersBetweenFairValueMeasurementLevelsAmount	0
CY2022	tdoc	Fair Value Assets And Liabilities Transfers Between Fair Value Measurement Levels Amount FairValueAssetsAndLiabilitiesTransfersBetweenFairValueMeasurementLevelsAmount	0
CY2022Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	30126000
CY2021Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	28540000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	433000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	597000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	31977000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	49146000
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	6194000
CY2022Q4	us-gaap	Inventory Net InventoryNet	56342000
CY2021Q4	us-gaap	Inventory Net InventoryNet	73079000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	63159000
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	38255000
CY2022Q4	tdoc	Deferred Device Cost And Other Current DeferredDeviceCostAndOtherCurrent	29956000
CY2021Q4	tdoc	Deferred Device Cost And Other Current DeferredDeviceCostAndOtherCurrent	22304000
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	25091000
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	21168000
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	12104000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5660000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	130310000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	87387000
CY2020Q4	us-gaap	Goodwill Goodwill	14581255000
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	64269000
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-55801000
CY2021	tdoc	Goodwill Measurement Period Adjustment Deferred Taxes GoodwillMeasurementPeriodAdjustmentDeferredTaxes	-66505000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-19044000
CY2021Q4	us-gaap	Goodwill Goodwill	14504174000
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12270000000
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-28172000
CY2022Q4	tdoc	Goodwill Reassignment To Reporting Units GoodwillReassignmentToReportingUnits	2206002000
CY2022Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1132812000
CY2022Q4	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	0
CY2022Q4	us-gaap	Goodwill Goodwill	1073190000
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3000000000.0
CY2022Q1	tdoc	Goodwill Impairment Loss Per Share GoodwillImpairmentLossPerShare	40.88
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6600000000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13400000000
CY2022	tdoc	Goodwill Impairment Loss Per Share GoodwillImpairmentLossPerShare	83.01
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	77353000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61364000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47712000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34130000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29641000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27234000
CY2022	us-gaap	Depreciation Depreciation	11400000
CY2021	us-gaap	Depreciation Depreciation	8900000
CY2020	us-gaap	Depreciation Depreciation	4800000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2421251000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	584486000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1836765000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2261768000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	351490000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1910278000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	244600000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	195300000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64700000
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	46100000
CY2021	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	15000000.0
CY2020	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	7500000
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	1535288000
CY2022Q4	tdoc	Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent	168693000
CY2021Q4	tdoc	Accrued Liabilities And Other Liabilities Excluding Accrued Compensation Current AccruedLiabilitiesAndOtherLiabilitiesExcludingAccruedCompensationCurrent	102933000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	287347000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	254686000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	233656000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	173698000
CY2022Q4	tdoc	Finite Lived Intangible Assets Amortization Expense Year Five And Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveAndThereafter	887378000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1836765000
CY2022	tdoc	Additional Amortization Expense Of Intangible Assets Related To Migration Strategy AdditionalAmortizationExpenseOfIntangibleAssetsRelatedToMigrationStrategy	23200000
CY2022	tdoc	Additional Amortization Expense Of Intangible Assets Related To Migration Strategy Per Share AdditionalAmortizationExpenseOfIntangibleAssetsRelatedToMigrationStrategyPerShare	0.14
CY2022Q4	tdoc	Cloud Computing Costs Net CloudComputingCostsNet	25400000
CY2021Q4	tdoc	Cloud Computing Costs Net CloudComputingCostsNet	2600000
CY2022	tdoc	Cloud Computing Expense CloudComputingExpense	1900000
CY2021	tdoc	Cloud Computing Expense CloudComputingExpense	100000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	10152000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7124000
CY2022Q4	tdoc	Accrued Consulting And Customer Service Fees Current AccruedConsultingAndCustomerServiceFeesCurrent	16407000
CY2021Q4	tdoc	Accrued Consulting And Customer Service Fees Current AccruedConsultingAndCustomerServiceFeesCurrent	19010000
CY2022Q4	tdoc	Other Current Liabilities Clients Guarantees OtherCurrentLiabilitiesClientsGuarantees	4145000
CY2021Q4	tdoc	Other Current Liabilities Clients Guarantees OtherCurrentLiabilitiesClientsGuarantees	3034000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1480000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1480000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3817000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3098000
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5981000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	3884000
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	35055000
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2958000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13592000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12687000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	10183000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9965000
CY2022Q4	tdoc	Other Current Liabilities Device Replacement Cost OtherCurrentLiabilitiesDeviceReplacementCost	349000
CY2021Q4	tdoc	Other Current Liabilities Device Replacement Cost OtherCurrentLiabilitiesDeviceReplacementCost	6263000
CY2022Q4	tdoc	Other Current Liabilities Accrued Rebates OtherCurrentLiabilitiesAccruedRebates	14542000
CY2021Q4	tdoc	Other Current Liabilities Accrued Rebates OtherCurrentLiabilitiesAccruedRebates	4619000
CY2022Q4	tdoc	Other Current Liabilities Staff Augmentation OtherCurrentLiabilitiesStaffAugmentation	3391000
CY2021Q4	tdoc	Other Current Liabilities Staff Augmentation OtherCurrentLiabilitiesStaffAugmentation	1858000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	49599000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	26953000
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	1225671000
CY2022Q4	tdoc	Advances From Financing Companies Customer Payments Due Year One AdvancesFromFinancingCompaniesCustomerPaymentsDueYearOne	11375000
CY2022Q4	tdoc	Advances From Financing Companies Customer Payments Due Year Two AdvancesFromFinancingCompaniesCustomerPaymentsDueYearTwo	6106000
CY2022Q4	tdoc	Advances From Financing Companies Customer Payments Due Year Three AdvancesFromFinancingCompaniesCustomerPaymentsDueYearThree	1976000
CY2022Q4	tdoc	Advances From Financing Companies Customer Payments Due AdvancesFromFinancingCompaniesCustomerPaymentsDue	19457000
CY2022	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	18473000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	14087000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	162000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1087000
CY2022	us-gaap	Lease Cost LeaseCost	18635000
CY2021	us-gaap	Lease Cost LeaseCost	15174000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	16854000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	14531000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11598000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M18D
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-575993000
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y8M15D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0608
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0588
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	15746000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	11078000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8519000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7607000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5340000
CY2022Q4	tdoc	Lessee Operating Lease Liability Payments Due Year Five And After Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive	12887000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	61177000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9543000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	51634000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13592000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38042000
CY2022	us-gaap	Restructuring Costs RestructuringCosts	7400000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	217852000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	302586000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	475531000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13303130000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-365762000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-566266000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-360213000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-18894000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-9727000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13663343000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-384656000
CY2021	tdoc	Effective Income Tax Rate Reconciliation Acquisition Expenses EffectiveIncomeTaxRateReconciliationAcquisitionExpenses	0.020
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1954000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3007000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	567000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	27000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1021000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2595000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1605000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4028000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3162000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-322000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	770000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	49008000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-60008000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5643000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6276000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-26775000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2967000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1757000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3752000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7840000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	40975000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-90535000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3812000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44137000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-90857000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.247
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.077
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.023
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.005
CY2020	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	126841000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	658409000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	687679000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4933000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	5413000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	52854000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	63641000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	3448000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	4814000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	0
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1320000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	19000
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	56000
CY2022Q4	tdoc	Deferred Tax Assets Interest Expenses Carryforward DeferredTaxAssetsInterestExpensesCarryforward	2677000
CY2021Q4	tdoc	Deferred Tax Assets Interest Expenses Carryforward DeferredTaxAssetsInterestExpensesCarryforward	11528000
CY2022Q4	tdoc	Deferred Tax Assets Operating Lease Assets DeferredTaxAssetsOperatingLeaseAssets	11012000
CY2021Q4	tdoc	Deferred Tax Assets Operating Lease Assets DeferredTaxAssetsOperatingLeaseAssets	13575000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7422000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7946000
CY2022Q4	tdoc	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	21987000
CY2021Q4	tdoc	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	0
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8590000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7032000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	771351000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	803004000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	415751000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	335810000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	355600000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	467194000
CY2022Q4	tdoc	Deferred Tax Liabilities Debt Restructure Costs DeferredTaxLiabilitiesDebtRestructureCosts	0
CY2021Q4	tdoc	Deferred Tax Liabilities Debt Restructure Costs DeferredTaxLiabilitiesDebtRestructureCosts	73378000
CY2022Q4	tdoc	Deferred Tax Liabilities Operating Lease Liabilities DeferredTaxLiabilitiesOperatingLeaseLiabilities	8701000
CY2021Q4	tdoc	Deferred Tax Liabilities Operating Lease Liabilities DeferredTaxLiabilitiesOperatingLeaseLiabilities	11842000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	551000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3427000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	396408000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	452049000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	879000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2275000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	406539000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	542971000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	50939000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	75777000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	415800000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	79900000
CY2022Q4	tdoc	Remaining Incremental Valuation Allowance After Adoption Of Su202006 RemainingIncrementalValuationAllowanceAfterAdoptionOfSU202006	18100000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	110848000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21362000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2912000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	59110000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	15850000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	12151000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	43399000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	20799000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1490000
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4990000
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2390000
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-14513000
CY2020	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	143798000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	110848000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21362000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	143800000
CY2022Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	6100000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13659531000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-428793000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-485136000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	161457123
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161457123
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156939349
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156939349
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	90509229
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90509229
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-84.60
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-84.60
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.73
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.73
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.36
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.36
CY2022	tdoc	Minimum Age Of Employee Eligible Under Plan MinimumAgeOfEmployeeEligibleUnderPlan	P21Y
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	300000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12100000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	11300000
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4900000
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2022	us-gaap	Revenues Revenues	2406840000
CY2021	us-gaap	Revenues Revenues	2032707000
CY2020	us-gaap	Revenues Revenues	1093962000
CY2022	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	246513000
CY2021	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	267837000
CY2022	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	246513000
CY2020	tdoc	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	126841000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13402812000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-43748000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9077000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-859000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5088000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-545000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9270000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-80365000
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-59950000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	256027000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	204239000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69495000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	217852000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	302586000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	475531000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	15620000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	26643000
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	88236000
CY2022	us-gaap	Restructuring Costs RestructuringCosts	7416000
CY2021	us-gaap	Restructuring Costs RestructuringCosts	0
CY2020	us-gaap	Restructuring Costs RestructuringCosts	0
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13663343000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-384656000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-575993000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3812000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	44137000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-90857000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-13659531000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-428793000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-485136000
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	29641000
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	27234000

Files In Submission

Name	View Source	Status
0001558370-23-002559-index-headers.html	Edgar Link	pending
0001558370-23-002559-index.html	Edgar Link	pending
0001558370-23-002559.txt	Edgar Link	pending
0001558370-23-002559-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tdoc-20221231.xsd	Edgar Link	pending
tdoc-20221231x10k.htm	Edgar Link	pending
tdoc-20221231x10k004.jpg	Edgar Link	pending
tdoc-20221231x10k011.jpg	Edgar Link	pending
tdoc-20221231x10k012.jpg	Edgar Link	pending
tdoc-20221231xex10d24.htm	Edgar Link	pending
tdoc-20221231xex10d24001.jpg	Edgar Link	pending
tdoc-20221231xex10d25.htm	Edgar Link	pending
tdoc-20221231xex21d1.htm	Edgar Link	pending
tdoc-20221231xex23d1.htm	Edgar Link	pending
tdoc-20221231xex31d1.htm	Edgar Link	pending
tdoc-20221231xex31d2.htm	Edgar Link	pending
tdoc-20221231xex32d1.htm	Edgar Link	pending
tdoc-20221231xex32d2.htm	Edgar Link	pending
tdoc-20221231xex4d10.htm	Edgar Link	pending
tdoc-20221231xex4d9.htm	Edgar Link	pending
tdoc-20221231_cal.xml	Edgar Link	unprocessable
tdoc-20221231_pre.xml	Edgar Link	unprocessable
tdoc-20221231_def.xml	Edgar Link	unprocessable
tdoc-20221231_lab.xml	Edgar Link	unprocessable
tdoc-20221231x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TDOC
Teladoc Health, Inc. Stock $tdoc

2023 Q1 Form 10-K Financial Statement

#000155837023002559 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TDOC Teladoc Health, Inc. Stock $tdoc

2023 Q1 Form 10-K Financial Statement

#000155837023002559 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TDOC
Teladoc Health, Inc. Stock $tdoc